Skip to content
Screener

Globus Medical GMED Pre-Tax Income

Discontinued — last reported Q2 '26

Pre-Tax Income at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$6.75B+3.9%
Stryker logo
StrykerSYK
$1.56B+53.9%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
-$15M-5.4%
Boston Scientific logo
Boston ScientificBSX
$1.06B+12.6%
IAR
Integra LifeSciencesIART
$4.74M+101%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$255.1M+13.6%

Segments

By segment

See full
Reportable Segment$189.82M+0.9%

Other financials

Income statement

See full
Revenue$789.6M+5.9%
Gross profit$548.2M+10.4%
Operating income$182.4M+140%
Net income$151.6M-25.3%
EPS (diluted)$1.10-26.2%

Balance sheet

See full
Cash & equivalents$507.7M+121%
Total debt$112.3M-7.6%
Total equity$4.8B+11.0%
Total assets$5.5B+10.6%

Cash flow

See full
Operating cash flow$209.7M+169%
CapEx$33.2M-28.8%
Free cash flow$176.6M+464%

Valuation

See full
Market cap$10.93B+52.9%
Enterprise value$10.54B+49.6%
P/E20.4×+0.4×
P/S3.5×+0.8×

Profitability

See full
Gross margin68.5%+5.8pp
Operating margin20.3%+9.6pp
Net margin17%+3.4pp
FCF margin24%+3.9pp

Returns & leverage

See full
Return on equity11.8%+3.2pp
Debt / equity0.0×
Current ratio4.6×+0.5×

Where this comes from

Reported directly by Globus Medical in its filing.

Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.

The source filing: Globus Medical’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 5:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-054450
(In thousands, except per share amounts)Three Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Bargain purchase gain110,5611,118110,561
Other income/(expense)1,1717723,4181,485
Total other income/(expense), net7,385112,06414,071118,728
Income/(loss) before income taxes189,817188,173346,891291,841
Income tax provision/(benefit)38,248(14,673)71,02013,533
Net income/(loss)$151,569$202,846$275,871$278,308
Other comprehensive income/(loss), net of tax:
Unrealized gain/(loss) on marketable securities(551)2(1,711)317

Item 1. Financial Statements

FAQ

What is Globus Medical's pre-tax income?
Globus Medical (GMED) reported pre-tax income of $189.82M in Q2 2026.
How has Globus Medical's pre-tax income changed year-over-year?
Globus Medical's pre-tax income increased by 0.9% year-over-year, from $188.17M to $189.82M.
What is the long-term trend for Globus Medical's pre-tax income?
Over 4 years (2021 to 2025), Globus Medical's pre-tax income has grown at a 35.3% compound annual growth rate (CAGR), from $180.41M to $605.07M.
What does pre-tax income mean?
Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.

Ask your AI about Globus Medical's pre-tax income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude